Related Experiment Video
Updated: Jun 27, 2025
Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma
Published on: September 15, 2023
Robotic thymectomy in thymic tumours: a multicentre, nation-wide study
Giovanni Maria Comacchio1, Marco Schiavon1, Carmelina Cristina Zirafa2
1Unit of Thoracic Surgery, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy.
Robot-assisted thoracoscopic thymectomy is a safe and effective procedure for thymic epithelial tumors, demonstrating excellent oncological outcomes and a low complication rate in a large multicenter study. This robotic approach offers a technically sound option for patients with these rare thoracic neoplasms.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Robotic Surgery
Background:
- Robotic thymectomy is technically feasible for thymic tumors but lacks long-term outcome data.
- Controversies persist regarding the surgical and oncological efficacy of robotic thymectomy.
- A large national multicenter study is needed to evaluate early and long-term outcomes.
Purpose of the Study:
- To evaluate the early and long-term outcomes of robot-assisted thoracoscopic thymectomy for thymic epithelial tumors.
- To assess the safety and efficacy of this minimally invasive approach.
- To address existing controversies regarding robotic thymectomy in thymic malignancies.
Main Methods:
- A retrospective analysis of 669 patients with thymic epithelial tumors undergoing robotic thoracoscopic thymectomy across 15 Italian centers (2002-2022).
- Collection and review of demographic, clinical, intraoperative, postoperative, pathological, and follow-up data.
- Assessment of complete resection, need for conversion to open surgery, perioperative mortality, and postoperative complications.
Main Results:
- 669 patients included, 46.6% with myasthenia gravis; 98% achieved complete thymectomy with R0 resection in 98.6%.
- Low conversion rate (3.4%) and no perioperative mortality; 7.7% postoperative complications.
- 5- and 10-year recurrence rates were 7.4% and 8.3%, respectively, with only 2 tumor-related deaths.
Conclusions:
- Robot-enhanced thoracoscopic thymectomy is a safe and technically sound procedure for thymic epithelial tumors.
- The approach is associated with a low complication rate and optimal oncological outcomes.
- This study provides robust evidence supporting robotic thymectomy in managing thymic malignancies.
